SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-061752
Filing Date
2011-03-10
Accepted
2011-03-10 09:25:37
Documents
12
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 947337
2 WAIVER TO CREDIT AGREEMENT dex101.htm EX-10.1 42684
3 STOCK WARRANT PURCHASE AGREEMENT dex102.htm EX-10.2 52033
4 RESTATED STOCK PURCHASE WARRANT NO. W-1 dex103.htm EX-10.3 76956
5 RESTATED STOCK PURCHASE WARRANT NO. W-2 dex104.htm EX-10.4 76809
6 STOCK PURCHASE WARRANT NO. W-3 dex105.htm EX-10.5 87463
7 AMENDMENT NO. 2 TO CREDIT AGREEMENT dex106.htm EX-10.6 133347
8 SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT dex107.htm EX-10.7 41078
9 CERTIFICATION OF CHIEF EXECUTIVE OFFICER, SECTION 302 dex311.htm EX-31.1 9380
10 CERTIFICATION OF CHIEF FINANCIAL OFFICER, SECTION 302 dex312.htm EX-31.2 9367
11 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 4575
12 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 4532
  Complete submission text file 0001193125-11-061752.txt   1486548
Mailing Address ONE CORPORATE WOODS DRIVE BRIDGETON MO 63044
Business Address ONE CORPORATE WOODS DRIVE BRIDGETON MO 63044 3146456600
KV PHARMACEUTICAL CO /DE/ (Filer) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-09601 | Film No.: 11676894
SIC: 2834 Pharmaceutical Preparations